1. Resveratrol induces apoptosis of benign prostatic hyperplasia epithelial cell line (BPH-1) through p38 MAPK-FOXO3a pathway
   Chao Li et al, 2019, BMC Complementary and Alternative Medicine CrossRef
2. Therapeutic Potential of Select Dietary Compounds in the Management of Hypertension and its Cardiovascular Complications
   Aleena Francis Valookaran et al, 2022, Molecules CrossRef
3. Dose-related Effects of Resveratrol in Different Models of Pulmonary Arterial Hypertension: A Systematic Review
   Andressa C. Ferreira et al, 2020, Current Cardiology Reviews CrossRef
4. Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension
   José L. Sánchez-Gloria et al, 2020, International Journal of Molecular Sciences CrossRef
5. A ring N(CH3)2-based derivative of resveratrol inhibits pulmonary vascular remodeling in hypoxia pulmonary hypertension
   Shuang Kong et al, 2023, European Journal of Pharmacology CrossRef
6. Pharmacological Effects and Potential Clinical Usefulness of Polyphenols in Benign Prostatic Hyperplasia
   Kensuke Mitsunari et al, 2021, Molecules CrossRef
7. FUT8-Mediated Core Fucosylation Promotes the Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
   Wen Zhang et al, 2023, Aging and disease CrossRef
8. Medicinal Plants and Phytochemicals for the Treatment of Pulmonary Hypertension
   Seyed Vahid Jasemi et al, 2020, Frontiers in Pharmacology CrossRef
9. Assessment of the Phytochemical Constituents and Metabolites in the Medicinal Plants and Herbal Medicine Used in the Treatment and Management of Respiratory Diseases
   Prasann Kumar et al, 2023, Herbal Medicine Phytochemistry CrossRef
10. Traditional Chinese medicine monomers: Targeting pulmonary artery smooth muscle cells proliferation to treat pulmonary hypertension
    Xiuli Yang et al, 2023, Heliyon CrossRef
11. Baicalin promotes apoptosis and inhibits proliferation and migration of hypoxia-induced pulmonary artery smooth muscle cells by up-regulating A2a receptor via the SDF-1/CXCR4 signaling pathway
    Xiaoying Huang et al, 2018, BMC Complementary and Alternative Medicine CrossRef
12. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation
    Wenhua Shi et al, 2018, Life Sciences CrossRef
13. Plant-Based Chemical Moieties for Targeting Chronic Respiratory Diseases
    Yinghan Chan et al, 2021, Targeting Cellular Signalling Pathways in Lung Diseases CrossRef
14. Impact of Nutrition on Pulmonary Arterial Hypertension
    María Callejo et al, 2020, Nutrients CrossRef
15. Multi-target natural products as alternatives against oxidative stress in Chronic Obstructive Pulmonary Disease (COPD)
    Priscila Baltazar Gonçalves et al, 2019, European Journal of Medicinal Chemistry CrossRef
16. Absence of the MFG‐E8 gene prevents hypoxia‐induced pulmonary hypertension in mice
    Jun Wang et al, 2021, Journal of Cellular Physiology CrossRef
17. Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension
    Zhifeng Xue et al, 2021, Frontiers in Pharmacology CrossRef
18. Resveratrol: Mechanistic and therapeutic perspectives in pulmonary arterial hypertension
    Elaheh Mirhadi et al, 2021, Pharmacological Research CrossRef
19. miR‐20a‐5p promotes pulmonary artery smooth muscle cell proliferation and migration by targeting ABCA1
    Yun Zhou et al, 2020, Journal of Biochemical and Molecular Toxicology CrossRef